Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PHF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DENND5B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APOB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
ZNF227 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CLIC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GM2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYO15B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
NR4A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARHGAP26 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SART1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TTC9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANP32C - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBBP7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MASP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BLVRA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AKR1C3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFYB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RRAD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on